Deborah Parlett
Family · Mays Landing, NJNPI 1508917832
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.4% of the total across 237 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 40 manufacturers, the largest accounting for just 18.0% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,529, more than ten times the $11 reported in 2020. Among family clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 237 payments — averaging $25.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- AstraZeneca$667
- Lilly USA, LLC$597
- Aimmune Therapeutics, Inc.$419
- Abbott$328
- Amgen$287
- plus $3K from 34 others
What the payments were for
- Food & beverage$5,91698%
- Education$451%
- Gifts$501%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 35 | $1,084 |
| AstraZeneca | 14 | $667 |
| Lilly USA, LLC | 25 | $597 |
| Aimmune Therapeutics, Inc. | 4 | $419 |
| Abbott | 9 | $328 |
| Amgen | 14 | $287 |
| Johnson & Johnson | 16 | $256 |
| Novo Nordisk | 16 | $242 |
| Bayer | 10 | $236 |
| Boehringer Ingelheim | 13 | $198 |
| Pfizer | 11 | $165 |
| Phathom Pharmaceuticals, Inc. | 4 | $149 |
| Gen-probe Sales & Service, Inc. | 1 | $146 |
| Nestle Healthcare Nutrition Inc. | 1 | $123 |
| Corcept Therapeutics | 7 | $120 |
| Kowa Pharmaceuticals America, Inc. | 8 | $115 |
| Esperion Therapeutics, Inc. | 6 | $89 |
| Bard Peripheral Vascular, Inc. | 1 | $74 |
| Astellas Pharma US Inc | 4 | $74 |
| OPKO Pharmaceuticals, LLC | 5 | $73 |
| E.r. Squibb & Sons, L.L.C. | 4 | $64 |
| Eisai Inc. | 4 | $60 |
| Sekisui Diagnostics LLC | 1 | $50 |
| Koya Medical, Inc. | 1 | $49 |
| Medtronic | 3 | $45 |
| Radius Health, Inc. | 2 | $36 |
| Lundbeck LLC | 2 | $30 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $28 |
| Hologic Sales And Service, LLC | 2 | $27 |
| Exact Sciences | 1 | $26 |
| Merck | 2 | $25 |
| Sumitomo Pharma America, Inc. | 1 | $17 |
| Dexcom, Inc. | 1 | $16 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| IBSA Pharma Inc. | 1 | $14 |
| Philips North America LLC | 1 | $14 |
| Daiichi Sankyo Inc. | 1 | $14 |
| Boston Scientific | 1 | $14 |
| Amarin Pharma, Inc. | 1 | $12 |
| Phadia US Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,011 in reported general payments places this provider in the 95th percentile of 2,692 family providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JanuviaSitagliptin Phosphate | 73 | $72,695 |
| TrulicityDulaglutide | 24 | $63,622 |
| JardianceEmpagliflozin | 46 | $57,210 |
| OzempicSemaglutide | 30 | $54,057 |
| FarxigaDapagliflozin Propanediol | 33 | $45,372 |
| EliquisApixaban | 20 | $31,417 |
| RybelsusSemaglutide | 11 | $30,008 |
| TradjentaLinagliptin | 11 | $14,249 |
| RestasisCyclosporine | 11 | $6,935 |
| Icosapent Ethyl | 11 | $5,247 |
| Ondansetron Hcl | 14 | $5,067 |
| Memantine Hcl | 12 | $4,698 |
| Rosuvastatin Calcium | 201 | $4,513 |
| SynthroidLevothyroxine Sodium | 46 | $4,152 |
| Levothyroxine Sodium | 298 | $3,247 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $242 | $84,06541 claims |
| MerckJanuvia | $25 | $72,69573 claims |
| Boehringer IngelheimJardiance, Tradjenta | $198 | $71,45957 claims |
| Lilly USA, LLCTrulicity | $597 | $63,62224 claims |
| AstraZenecaFarxiga | $667 | $45,37233 claims |
| PfizerEliquis, Dilantin | $165 | $33,85732 claims |
| AbbVieRestasis, Synthroid | $1,084 | $11,08757 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,692 family providers in New Jersey.
Other family in Mays Landing
- Jennifer DemaioMorristown$412K
- Kara TrlicaCranbury$186K
- Nicole BauerParamus$161K
- China BattistaWall Township$142K
- Nancy EisenbergerVoorhees$82K
- Jennifer AbitabiloGlen Ridge$54K
- Megan FiloramoMorristown$53K
- Shawn DenningToms River$29K
- Kimberly ClementeEatontown$25K
- Toni Michelle SeibertColumbus$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.